Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial
Purpose: Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spare adjacent critical organs, improving toxicity profiles and potentially improving clinical outcomes. Methods and Materials: We evaluated the REG001-...
Main Authors: | Jacob S. Parzen, MD, Michael D. Chuong, MD, John Chang, MD, Lane Rosen, MD, James Urbanic, MD, William Hartsell, MD, Henry Tsai, MD, Christopher Sinesi, MD, Jing Zeng, MD, Mark Mishra, MD, Carlos Vargas, MD, Craig Stevens, MD, PhD, Peyman Kabolizadeh, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109421001093 |
Similar Items
-
Optimization of Field Design in the Treatment of Rectal Cancer with Intensity Modulated Proton Beam Radiation Therapy: How Many Fields Are Needed to Account for Rectal Distension Uncertainty?
by: Jacob S. Parzen, MD, et al.
Published: (2021-09-01) -
Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
by: Zhenwei Zou, MD, et al.
Published: (2020-05-01) -
Beam-Specific Spot Guidance and Optimization for PBS Proton Treatment of Bilateral Head and Neck Cancers
by: Karla Leach, BS, et al.
Published: (2021-06-01) -
Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers
by: Norihiro Aibe, MD, PhD, et al.
Published: (2021-07-01) -
Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial
by: Takeo Odaka, MD, PhD, et al.
Published: (2017-01-01)